aod9604 visceral fat How AOD-9604 Targets Cells: Complete Adipose Metabolism Guide AOD-9604 vs MOTS-c vs Tesamorelin

First, a bacterial reverse mutation test (Ames test) assessed AOD9604s mutagenic potential using four histidine-dependent auxotrophic mutants of Salmonella typhimurium (TA1535, TA1537, TA98, TA100) and one tryptophan-dependent auxotrophic mutant of Escherichia coli (WP2 uvrA), using both plate incorporation and pre-incubation methods at doses of 0, 1.6, 8, 40, 200, 1,000, and 2,000 g AOD9604/plate

Any statements regarding therapeutic use have not been evaluated by the FDA.

[26] Individuals with severe liver disease or with a condition called metabolic acidosis are also contraindicated for Lipo-B

Peptide Vials 5 mg AOD-9604 vials